XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (9,676,201) $ (7,970,269)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,060,571 497,373
Amortization of debt discount 228,499 143,257
Non-cash equity-based compensation expense 3,295,029 2,963,702
Change in operating assets and liabilities:    
Inventory (351,990) (178,780)
Accounts receivable (547,032)
Prepaid expenses and other assets 91,640 (45,501)
Deferred charges (21,289)
Deferred revenues 140,519
Operating lease liabilities (505,920) (171,963)
Accretion operating lease liabilities 245,009
Royalty obligation (200,000)
Accounts payable and accrued expenses 303,866 398,183
Net cash used in operating activities (6,182,308) (4,118,989)
Cash flows from investing activities:    
Purchase of debt securities (136,033)
Purchase of property and equipment (53,647) (306)
Payment of patent costs and other intangibles (33,559)
Net cash used in investing activities (53,647) (169,898)
Cash flows from financing activities:    
Proceeds from issuance of common stock- offerings 3,655,755
Proceeds from issuance of convertible notes 10,350,000
Principal repayments of notes payable (60,390) (893)
Net cash provided by financing activities 3,595,365 10,349,107
Change in cash, cash equivalents and restricted cash (2,640,590) 6,060,221
Cash, cash equivalents, and restricted cash at beginning of period 22,430,253 9,461,597
Cash, cash equivalents and restricted cash at end of period 19,789,663 15,521,818
Supplementary disclosure of non-cash financing activities:    
Substitution of consideration payable to convertible notes 3,117,408
Debt discount 5,569,978
 Right-of-use assets and operating lease liabilities 662,698
Cash paid during the period for:    
Interest $ 641,647 $ 711,648